Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive initial results from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback